Status:
UNKNOWN
Supplementation With Vitamin D to Patients With Heart Failure (D-Heart).
Lead Sponsor:
Linkoeping University
Conditions:
Heart Failure With Reduced Ejection Fraction
Vitamin D Deficiency
Eligibility:
All Genders
Phase:
NA
Brief Summary
In 200 patients with documented systolic heart failure give supplementation with vitamin D in those with a 25-OH- vitamin D \< 50nmol/L - or placebo. In those with a vitamin D level \<25nmol/L a subs...
Detailed Description
In a population with a systolic heart failure with an EF\<40%, the levels of vitamin D will be analysed. In those with a 25-OH-vitamin D level \<50nmol/L the patients that accept participation, will b...
Eligibility Criteria
Inclusion
- Patients with documented and stable systolic heart failure and connected to an outpatient clinic at the Dept of Cardiology in Linköping, or Jönköping, Sweden, and with a 25-OH-vitamin D \<50nmol/L
Exclusion
- Patients with unstable heart failure
- Patients with significant valvular disease, or ischemic heart disease planned for operation
- Patients with significant renal or /and liver impairment.
- Patients that do not understand that study information, or that are not willing to participate
Key Trial Info
Start Date :
February 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 1 2020
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT03289637
Start Date
February 1 2018
End Date
February 1 2020
Last Update
March 7 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dept of Cardiology, University Hospital of Linköping
Linköping, Sweden, 58191